Insulet

Insulet Corporation is a medical device company dedicated to simplifying life for people living with diabetes through the use of its Omnipod technologies, a tubeless insulin delivery device. It has established a strong position in the wearable medical device market by combining automation, convenience, and user-centred design to simplify insulin management.

- Analysts: Peet Serfontein, Khumbulani Kunene

Technically, a steep, rising channel (see the black parallel trendlines on the main chart) has been in place since May 2024, and reflects a well-established upward trend defined by progressively higher highs and higher lows.

The insert shows an AI model based on forward calculated price targets for the stock. The model downloads seven years of price data, cleans and adjusts it for corporate actions and then builds a wide range of technical indicators. The recent price shows a steady recovery, and the model projects a continued upward bias across the one-, three-, six- and 12-month horisons, supporting the bullish stance.

Fading downside price momentum per the MACD histogram and the recent sideways trajectory of the on-balance volume (OBV) indicator also supports our bullish view.

Technical analysis

The lower panel shows occurrences of the Three Outside Up Japanese candlestick pattern. A reading of one indicates when such a pattern occurred. This pattern is a classic bullish reversal signal, and reflects a clear shift in sentiment from bearish to bullish.